In recent years, genetically re-engineered immune cells – armed with molecular weaponry to recognize and destroy tumor cells – have changed the landscape of cancer treatment. Now, a team of UCSF researchers led by Kole Roybal, PhD, have developed a new method for comparing massive numbers of these CAR-T cells, each with slightly different molecular features, to determine which is most effective and long-lasting against cancer. [read more]
|
|
|
|
In the latest CureTalks podcast, Dr. Hala Borno discusses her innovative approaches to improving diversity, equity, and inclusion in cancer clinical trials. |
|
|
|
A study co-led by researchers at UCSF and MD Anderson suggests the mechanisms behind why myocarditis associated with cancer immunotherapies may occur more frequently in female patients. |
|
Cancer Grand Challenges: Submit Your Ideas |
|
|
|
The NCI-Cancer Research UK Cancer Grand Challenges initiative brings together international research teams to tackle cancer’s toughest challenges. Submit your ideas for the next round of challenge opportunities by Nov 28! |
|
Chou J, Egusa EA, Wang S, Badura ML, Lee F, Bidkar AP, Zhu J, Shenoy T, Trepka K, Robinson TM, Steri V, Huang J, Wang Y, Small EJ, Chan E, Stohr BA, Ashworth A, Delafontaine B, Rottey S, Cooke KS, Hashemi Sadraei N, Yu B, Salvati M, Bailis JM, Feng FY, Flavell RR, Aggarwal R. Immunotherapeutic targeting and PET imaging of DLL3 in small cell neuroendocrine prostate cancer. Cancer Res. 2022 Nov 9:CAN-22-1433. |
|
Nov 19, 2022 | 10:30 am - 2:00 pm
Co-presented by the UCSF Abundant Life Health Ministries Network, this community health fair offers colorectal cancer screenings, diabetes info, vaccinations, rapid tests, and more. |
|
|
In a recent lecture hosted by the HDFCCC Office of Community Engagement, Dr. Leticia Márquez-Magaña addressed the health effects of structural racism and culturally relevant coping mechanisms for racism stress. |
|
This HDFCCC program provides salary support for protected research, clinical trial, career development, and leadership training. Apply by Jan 13, 2023.
|
|
|
Dec 5, 2022 | 4:00 - 6:00 pm | Parnassus
Dec 6, 2022 | 4:45 - 6:45 pm | Mission Bay
This event is designed to introduce the vibrant cancer research community at UCSF to the 1st year students across PhD and MD/PhD programs who wish to pursue a degree in cancer biology. Open to entire UCSF community. Learn more and register.
|
|
Feb 1, 2023 | 9:00 am - 1:00 pm
This event helps match UCSF faculty with post-bacc trainees who are eligible for an NIH-diversity supplement. Event allows faculty to have approximately 8 short, virtual interviews to meet eligible trainees. Register by Jan 6, 2023.
|
|
A note from @UCSFCancer: UCSF Twitter users are responding to the channel's recent changes in a variety of ways -- by pausing accounts, moving to other platforms such as Mastadon, or purposefully continuing to tweet. For the time being, we will continue to use Twitter for promotion of HDFCCC excellence and opportunities while investigating other channels. |
|
This CME webinar features presentations by experts at UCSF and John Muir Health including Drs. Thomas Martin, Laura Huppert, Matthew Gubens, and Andrew Ko.
Francisco M. Barriga, PhD (cancer biologist candidate) will present, "Dissecting the Function of Copy Number Alterations in Cancer."
Representatives from ASCO, AACR, American Cancer Society, and the Damon Runyon Cancer Research Foundation will present funding opportunities and tips for applying.
Sabrina Spencer, PhD (University of Colorado Boulder) will present, "Rapid escape from quiescence induced by targeted MAPK pathway inhibitors."
This three-day conference features tracks on Emerging Therapeutics, AI & Data Sciences, Diagnostics & Molecular Profiling in the Clinic, and Next Generation Technologies.
|
|
|
|
|
|
|
